Christopher M Starr's Net Worth
Estimate Recalculated Nov 1, 2024 11:30AM EST
Who is Christopher M Starr
Christopher M Starr has an estimated net worth of $36.5 Million. This is based on reported shares across multiple companies, which include RAPTOR PHARMACEUTICALS CORP., Monopar Therapeutics, Raptor Pharmaceutical Corp, and BIOMARIN PHARMACEUTICAL INC.
SEC CIK
Christopher M Starr's CIK is 0001235470
Past Insider Trading and Trends
2014 was Christopher M Starr's most active year for acquiring shares with 19 total transactions. Christopher M Starr's most active month to acquire stocks was the month of August. 2014 was Christopher M Starr's most active year for disposing of shares, totalling 29 transactions. Christopher M Starr's most active month to dispose stocks was the month of March. 2006 saw Christopher M Starr paying a total of $165,000.00 for 250,000 shares, this is the most they've acquired in one year. In 2016 Christopher M Starr cashed out on 1,324,459 shares for a total of $6,429,555.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RAPTOR PHARMACEUTICALS CORP.
Form 4 | — | — | — | — | Oct 01, 2009 | — | — | — | — |
Form 4 | — | 250.00K | $0.66 | $165.00K | May 31, 2006 | 250.00K | Grant | — | May 26 |
Form 3 | — | — | — | — | May 31, 2006 | 3.00M | — | — | — |
Form 4 | — | — | — | — | Jan 03, 2024 | 75.26K | Options | — | Dec 31 |
Form 4 | — | — | — | — | Oct 03, 2023 | 75.26K | Options | — | Sep 30 |
Form 4 | — | — | — | — | Jul 03, 2023 | 75.26K | Options | — | Jun 30 |
Form 4 | — | — | — | — | Apr 04, 2023 | 75.26K | Options | — | Mar 31 |
Form 4 | — | 24.06K | — | — | Feb 03, 2023 | 24.06K | Grant | — | Feb 01 |
Form 4 | — | — | — | — | Jan 03, 2023 | 65.13K | Options | — | Dec 31 |
Form 4 | — | — | — | — | Oct 03, 2022 | 65.13K | Options | — | Sep 30 |
Form 4 | — | — | — | — | Jul 01, 2022 | 65.13K | Options | — | Jun 30 |
Form 4 | — | — | — | — | Apr 01, 2022 | 65.13K | Options | — | Mar 31 |
Form 4 | — | 26.56K | — | — | Feb 04, 2022 | 26.56K | Grant | — | Feb 02 |
Form 4 | — | — | — | — | Jan 04, 2022 | 53.69K | Options | — | Dec 31 |
Form 4 | — | — | — | — | Oct 01, 2021 | 53.69K | Options | — | Sep 30 |
Form 4 | — | — | — | — | Jul 02, 2021 | 53.69K | Options | — | Jun 30 |
Form 4 | — | — | — | — | Apr 01, 2021 | 53.69K | Options | — | Mar 31 |
Form 4 | — | 7.45K | — | — | Jan 28, 2021 | 7.45K | Grant | — | Jan 26 |
Form 4 | — | — | — | — | Jan 05, 2021 | 50.69K | Options | — | Sep 30 - Dec 31 |
Form 4 | — | — | — | — | Jul 02, 2020 | 50.69K | Options | — | Jun 30 |
Form 4 | — | — | — | — | Apr 01, 2020 | 50.69K | Options | — | Mar 31 |
Form 4 | — | 6.93K | — | — | Feb 20, 2020 | 6.94K | Grant | — | Jan 31 |
Form 4 | — | 26.10K | — | — | Sep 27, 2018 | 75.50K | Grant | — | Aug 09 |
Form 3 | — | — | — | — | Jan 08, 2018 | 49.40K | — | — | — |
Raptor Pharmaceutical Corp
Form 4 | -100.00% | -1.32M | $9.00 | -$6.43M | Oct 26, 2016 | — | Disposition | — | Oct 24 - Oct 25 |
Form 4 | 1.18% | 8.33K | — | — | Jun 27, 2016 | 714.40K | Grant | — | Jun 23 |
Form 4 | 3.43% | 24.02K | — | — | May 21, 2015 | 725.06K | Grant | — | May 19 |
Form 4 | -2.78% | -20.03K | $7.58 | -$161.81K | Mar 25, 2015 | 701.04K | Sale | Scheduled | Mar 23 |
Form 4 | -4.00% | -30.02K | $7.63 | -$245.29K | Mar 18, 2015 | 721.08K | Sale | Scheduled | Mar 16 |
Form 4 | -3.84% | -30.00K | $6.53 | -$179.45K | Feb 25, 2015 | 751.10K | Sale | Scheduled | Feb 24 |
Form 4 | -3.70% | -30.00K | $6.46 | -$174.91K | Feb 19, 2015 | 781.10K | Sale | Scheduled | Feb 17 |
Form 4 | 1.14% | 8.01K | — | — | Feb 11, 2015 | 707.38K | Grant | — | Feb 09 |
Form 4 | -3.57% | -30.00K | $6.49 | -$177.37K | Jan 26, 2015 | 809.42K | Sale | Scheduled | Jan 22 |
Form 4 | -3.45% | -30.00K | $6.64 | -$185.77K | Jan 20, 2015 | 839.42K | Sale | Scheduled | Jan 15 |
Form 4 | -3.34% | -30.00K | $6.27 | -$163.85K | Dec 23, 2014 | 869.42K | Sale | Scheduled | Dec 22 |
Form 4 | -3.23% | -30.00K | $5.85 | -$138.38K | Dec 17, 2014 | 899.42K | Sale | Scheduled | Dec 15 |
Form 4 | -3.13% | -30.00K | $6.76 | -$192.77K | Nov 25, 2014 | 929.42K | Sale | Scheduled | Nov 24 |
Form 4 | -3.03% | -30.00K | $6.73 | -$191.05K | Nov 19, 2014 | 959.42K | Sale | Scheduled | Nov 17 |
Form 4 | -4.11% | -30.00K | $6.61 | -$218.32K | Oct 24, 2014 | 699.37K | Sale | Scheduled | Oct 22 |
Form 4 | -3.95% | -30.00K | $6.51 | -$211.96K | Oct 17, 2014 | 729.37K | Sale | Scheduled | Oct 15 |
Form 4 | -3.89% | -30.00K | $6.59 | -$217.33K | Sep 25, 2014 | 741.40K | Sale | Scheduled | Sep 23 |
Form 4 | -4.09% | -32.90K | $6.75 | -$253.67K | Sep 18, 2014 | 771.40K | Sale | Scheduled | Sep 16 |
Form 4 | -1.71% | -19.32K | $6.96 | -$148.11K | Mar 19, 2014 | 1.11M | Sale | Scheduled | Mar 17 |
Form 4 | -2.17% | -25.00K | $9.23 | -$301.59K | Feb 20, 2014 | 1.13M | Sale | Scheduled | Feb 18 |
Form 4 | — | 195.62K | — | — | Feb 11, 2014 | 195.62K | Grant | — | Feb 07 |
Form 4 | -2.39% | -25.00K | $9.28 | -$307.19K | Jan 17, 2014 | 1.02M | Sale | Scheduled | Jan 15 |
Form 4 | -2.44% | -25.00K | $7.99 | -$268.24K | Dec 18, 2013 | 999.08K | Sale | Scheduled | Dec 16 |
Form 4 | -2.38% | -25.00K | $7.47 | -$241.93K | Nov 19, 2013 | 1.02M | Sale | Scheduled | Nov 15 |
Form 4 | -2.35% | -25.00K | $8.37 | -$269.98K | Oct 17, 2013 | 1.04M | Sale | Scheduled | Oct 15 |
Form 4 | -2.01% | -25.00K | $8.61 | -$280.18K | Sep 18, 2013 | 1.87M | Sale | Scheduled | Sep 16 |
Form 4 | -0.53% | -10.09K | $3.85 | -$36.92K | Jan 02, 2013 | 1.89M | Sale | Scheduled | Dec 31 |
Form 4 | -0.32% | -10.09K | $4.06 | -$26.72K | Oct 01, 2012 | 3.11M | Sale | Scheduled | Sep 28 |
Form 4 | 14.12% | 150.00K | — | — | Sep 27, 2012 | 1.21M | Grant | — | Sep 25 |
Form 4 | -0.57% | -10.09K | $4.22 | -$27.93K | Jul 02, 2012 | 1.76M | Sale | Scheduled | Jun 29 |
Form 4/A | -0.57% | -10.09K | $4.78 | -$39.27K | May 09, 2012 | 1.77M | Sale | Scheduled | Apr 02 |
Form 4 | -0.46% | -10.09K | $4.78 | -$39.27K | Apr 04, 2012 | 2.17M | Sale | Scheduled | Apr 02 |
Form 4/A | 73.89% | 460.06K | — | — | Sep 28, 2011 | 1.08M | Grant | — | Sep 22 |
Form 4 | 73.89% | 460.06K | — | — | Sep 26, 2011 | 1.08M | Grant | — | Sep 22 |
Form 4/A | — | — | — | — | Feb 18, 2011 | 622.61K | — | — | — |
Form 4 | 328.53% | 345.05K | — | — | Nov 23, 2010 | 450.09K | Grant | — | Nov 22 |
Form 4 | 164.26% | 172.52K | — | — | Oct 13, 2010 | 277.56K | Grant | — | Oct 12 |
Form 4 | 80.21% | 46.75K | — | — | Mar 11, 2010 | 105.03K | Grant | — | Mar 09 |
Form 3/A | — | — | — | — | Oct 09, 2009 | — | — | — | — |
Form 4 | — | 757.65K | $0.01 | $6.99K | Oct 01, 2009 | 757.65K | Grant | — | Sep 29 |
Form 3 | — | — | — | — | Oct 01, 2009 | — | — | — | — |
Form 4 | -2.20% | -16.14K | $10.00 | -$105.71K | Dec 02, 2005 | 717.85K | Sale | Scheduled | Dec 01 |
Form 4 | -0.37% | -5.00K | $10.00 | -$105.71K | Nov 23, 2005 | 1.33M | Sale | Scheduled | Nov 21 |
Form 4 | 16.05% | 60.00K | — | — | Jan 10, 2005 | 433.81K | Grant | — | Jan 07 |
Form 4 | -3.17% | -10.00K | $7.64 | -$76.37K | Jun 04, 2004 | 305.18K | Sale | Scheduled | Jun 03 |
Form 4 | -0.80% | -5.57K | $6.00 | -$22.28K | Apr 05, 2004 | 688.99K | Sale | Scheduled | Apr 02 |
Form 4 | -1.56% | -5.00K | $7.56 | -$37.79K | Apr 02, 2004 | 315.18K | Sale | Scheduled | Apr 01 |
Form 4 | 24.64% | 75.00K | — | — | Jan 02, 2004 | 379.38K | Grant | — | Dec 31 |
Form 4 | -5.02% | -33.00K | $6.50 | -$227.00K | Aug 22, 2003 | 624.56K | Sale | Scheduled | Aug 21 |
Form 4 | — | — | — | — | Jul 16, 2003 | — | — | Scheduled | — |
